Skip to main content
. 2022 Mar 2;150:e59. doi: 10.1017/S0950268822000425

Fig. 3.

Fig. 3.

Average effectiveness (per cent; 95% cluster-robust CIs) of the COVID-19 vaccination during 2021 weeks 10–44 in protecting infection, hospitalisation and severe disease (oxygen supply ≥5 l/min or ICU admittance) in relation to vaccine type and time since last dose.